Pacific Biosciences of California
Pacific Biosciences of California (PACB), which is engaged in design, development and commercialization of innovative tools for biological research, is trading up 8.1% to $2.39 in recent trading.
Today's Range: $2.20-$2.40
52-Week Range: $1.06-$3.99Volume: 327,000 Three-Month Average Volume: 514,302 From a technical perspective, PACB is soaring higher here right above some near-term support at $2.16 to $2.13 with solid upside volume. This move is quickly pushing shares of PACB within range of triggering a near-term breakout trade. That trade will hit if PACB manages to take out its 50-day at $2.39 and then once it clears more overhead resistance levels at $2.64 to $2.73 with high volume. Traders should now look for long-biased trades in PACB as long as it's trending above $2.16, and then once it sustains a move or close above those breakout levels with volume that hits near or above 514,302 shares. If that breakout triggers soon, then PACB will set up to re-test or possibly take out its next major overhead resistance levels at $3.25 to $3.99. LCA-Vision LCA-Vision (LCAV) is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. This stock is trading up 6.3% to $3.35 in recent trading. Today's Range: $3.15-$3.36 52-Week Range: $2.67-$7.50 Volume: 86,000 Three-Month Average Volume: 102,995 From a technical perspective, LCAV is ripping higher here back above its 50-day moving average of $3.14 with decent upside volume. This stock recently formed a double bottom at around $2.78 to $2.83 and it has now broken out above some near-term overhead resistance levels at $3.08 to its 50-day at $3.14. Shares of LCAV are now quickly moving within range of triggering another major breakout trade. That trade will hit if LCAV manages to take out some near-term overhead resistance levels at $3.50 to $3.60 and then once it clears its 200-day at $3.68 with high volume. Traders should now look for long-biased trades in LCAV as long as it's trending above its 50-day at $3.14, and then once it sustains a move or close above those breakout levels with volume that hits near or above 102,995 shares. If that breakout triggers soon, then LCAV will set up to re-test or possibly take out its next major overhead resistance levels at $4.10 to $4.32. Any high-volume move above those levels will then put $4.60 into range for shares of LCAV.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts